# Eurofins Lancaster Laboratories, Inc – FDA Inspection, Aug 26, 2025

Source: https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/204a3e19-1058-4e10-b09a-d0d509c4df22
Source feed: FDA_Inspections

> FDA inspection 1279557 of Eurofins Lancaster Laboratories, Inc, August 26, 2025. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1279557
- Company Name: Eurofins Lancaster Laboratories, Inc
- Inspection Date: 2025-08-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Philadelphia District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1284580 - 2025-09-23](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/d905bc5d-0d6c-4d5e-b731-266193c1d3d1)
- FDA Inspection 1156933 - 2021-10-21
- FDA Inspection 1113269 - 2019-10-17
- FDA Inspection 1106449 - 2019-09-13
- FDA Inspection 1031761 - 2017-10-19

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/junho-pak/4abe53fb-ad20-490d-9e71-6216a9f863f5)

Company: https://www.keypedia.com/companies/eurofins-lancaster-laboratories-inc/fdb282e8-01fc-4626-8794-1b7394ba0890

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8
